1.

Characteristics of undocumented migrants and uninsured legal residents (N = 784) who participated in the Kruispost study to screen for HBV, HCV and HIV, in Amsterdam, the Netherlan...

1.

Characteristics of undocumented migrants and uninsured legal residents tested for HBV (N = 438) by HBV status, in Amsterdam, the Netherlands, October 2018- October 2019.

1.

Determinants of HBV exposure among undocumented migrants and uninsured legal residents that were tested for HBV (n = 130/438) in Amsterdam, the Netherlands, October 2018—October 20...

1.

Characteristics of undocumented migrants and uninsured legal residents tested for HCV (N = 435) by HCV status, in Amsterdam, the Netherlands, October 2018- October 2019.

1.

Characteristics of undocumented migrants and uninsured legal residents tested for HIV (N = 439) by HIV status, in Amsterdam, the Netherlands, October 2018- October 2019.

1.

Review of Michael W. Cole and Rebecca Zorach (eds), The Idol in the Age of Art -- Objects, Devotions and the Early Modern World

2.

Review of Michael W. Cole and Rebecca Zorach (eds), The Idol in the Age of Art -- Objects, Devotions and the Early Modern World

3.

Review of Michael W. Cole and Rebecca Zorach (eds), The Idol in the Age of Art -- Objects, Devotions and the Early Modern World

1.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

2.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

3.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

4.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

5.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

6.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

7.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

8.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

9.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

1.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

2.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

3.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

4.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

5.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

6.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

7.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

8.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

9.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

1.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

2.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

3.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

4.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

5.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

6.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

7.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

8.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

9.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

1.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

2.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

3.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

4.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

5.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

6.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

7.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.